Pictet Asset Management Holding Sa Syndax Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 12,356 shares of SNDX stock, worth $185,834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,356Holding current value
$185,834% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
247Shares Held
100MCall Options Held
1.28MPut Options Held
1.29M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$128 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$119 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$87.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.03MShares$75.7 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$61.1 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $851M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...